![ESMO-Webinar-series-Taxonomy-Tumour-Agnostic-Therapeutics-1000x250](/var/esmo/storage/images/media/esmo/meetings/2024/_webinars/images/webinar-series/precision-oncology-genomics-guided-care/esmo-webinar-series-taxonomy-tumour-agnostic-therapeutics-1000x250/18325634-1-eng-GB/esmo-webinar-series-taxonomy-tumour-agnostic-therapeutics-1000x250_i770.jpg)
Login to get immediate access to this content.
LoginLearning objectives:
- To discuss a proposal for a taxonomy of tissue agnostic therapeutics.
- To highlight the scientific issues and clinical trial designs pertaining to the development of oncology drugs agnostic of tumour type.
- To explore the opportunities and challenges in development of a framework for drug development in a tumour agnostic manner.